Erin Frances Cobain, MD

Dr. Erin Cobain is a medical oncologist specializing in the care of patients with breast cancer and inherited cancer predisposition. She serves at Co-Director of the Breast Cancer Clinical Research Team at the Rogel Cancer Center. Dr. Cobain has been on faculty at the University of Michigan since 2016, when she completed her fellowship training.

Dr. Cobain specializes in the care of patients with all types of breast cancer and those individuals who are at high risk of developing breast cancer. Dr. Cobain’s research interests include understanding how genetic and genomic testing can be utilized to personalize breast cancer therapy and use of immunotherapy treatments in breast cancer. Dr. Cobain serves as the Principal Investigator of a National Cancer Institute sponsored clinical trial exploring the role of combination chemotherapy and immunotherapy treatment in patients with hormone receptor positive, HER2 negative early-stage breast cancer with high genomic risk.

University of Michigan Health participates with most health insurance plans.

Dr. Cobain’s research focuses on identifying those at high risk of developing breast cancer and personalizing therapy for those with a breast cancer diagnosis through genetic and genomic testing. Dr. Cobain has a particular interest in identifying which patients with breast cancer may benefit most from immunotherapy-based treatment. She works closely with colleagues at the University of Michigan as well as the SWOG Cancer Research Network to develop clinical trials that incorporate tumor biomarker testing.

To see a full list of clinical trials available through the University of Michigan Breast Care Center.